Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

17.56 -0.50 (-2.77%)
Official Closing Price Updated: 7:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
29 30 Next >
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to... 
Via Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
 
Via Benzinga
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
 
Via Benzinga
Stocks Move Higher As Wall Street Eyes China Lockdowns
The Dow Jones Industrial Average is up 271 points midday, while the Nasdaq Composite and S&P 500 Index are firmly higher as well. 
Via Talk Markets
Teva Finalizes Nationwide Opioid Settlement Terms
From Teva Pharmaceutical Industries Limited
Via Business Wire
Why Teva Stock Sank On Thursday
There were two major developments with the company, both of which involved piles of money. 
Via The Motley Fool
Teva Highlights Long-Term Data From Chorea Associated-Huntington's Treatment
 
Via Benzinga
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share. 
Via InvestorPlace
TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO. 
Via InvestorPlace
Teva Announces Appointment of Richard Francis as President and CEO
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health Platform
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
From Teva Pharmaceutical Industries Limited
Via Business Wire
AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday
Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at... 
Via Benzinga
Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M
A federal jury has asked Eli Lilly And Company (NYSE: LLY) to pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three... 
Via Benzinga
Adding $100 to These 5 Stocks Would Be a Genius Move Right Now
You don't need a large pile of cash to begin building wealth on Wall Street. 
Via The Motley Fool
Teva to Present Latest Research from the CONNECT1 and CONNECT2 Clinical Trials at the American College of Allergy, Asthma & Immunology (ACAAI) 2022 Annual Scientific Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Why Teva Stock Stumbled Again on Friday
A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments. 
Via The Motley Fool
Teva Pharmaceutical Industries (TEVA) Q3 2022 Earnings Call Transcript
TEVA earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Teva Pharmaceutical Posts Lower Q3 Sales & Profits, Trims FY22 Revenue Outlook
 
Via Benzinga
Recap: Teva Pharmaceutical Q3 Earnings
Teva Pharmaceutical Indus (NYSE:TEVA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Teva Reports Third Quarter 2022 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved Communities – Awarded Funding from Teva Pharmaceuticals, Direct Relief and NAFC
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
From Teva Pharmaceutical Industries Limited
Via Business Wire
Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13
Reuters 
Via Benzinga
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
FDA Signals Shortage For Teva Pharma's ADHD Drug Due To Manufacturing Delay
The FDA said that there was a shortage of Adderall after intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd (NYSE: TEVA). 
Via Benzinga
Teva Under Suspicion On Practices To Stave Off Copaxone Competition
The European Commission, in an interim view, says Teva Pharmaceutical Industries Ltd (NYSE: TEVA) breached European Union (EU) antitrust rules over practices delaying competition to the multiple... 
Via Benzinga
Teva Reaches Agreement With Arkansas to Settle the State’s Price Fixing Claims
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Largest-Ever Trial to Collect Information from Patients and Physicians About TD, its Impact and Progression Over Time, and Evaluate Treatment-Related Outcomes
From Teva Pharmaceutical Industries Limited
Via Business Wire
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.